Multilineage Potential of Adult Human Mesenchymal Stem Cells
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, harvesting BM-MSCs is limited by the potential pain and morbidity associated with bone marrow aspiration, and only a small fraction (0.001–0.01%) of harvested bone marrow cells are MSCs [58,67].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [67]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2011) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells
Till, J. E., & McCulloch, E. A. (1961) · Radiation Research · doi:10.2307/3570892 · Cited by 3,708
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.
Wakitani, S., Goto, T., Pineda, S. J., Young, R. G., Mansour, J. M., Caplan, A. I., & Goldberg, V. M. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199404000-00013 · Cited by 1,605
Bruder, S. P., Jaiswal, N., & Haynesworth, S. E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f · Cited by 1,485
Derivation of pluripotent stem cells from cultured human primordial germ cells
Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., & Gearhart, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13726 · Cited by 1,420
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Research works printed but not linked: 4
- ; M. Owen and A. J. Friedenstein in Cell and Molecular Biology of Vertebrate Hard Tissues D. Evered and S. Harnett Eds. (Wiley Chichester UK 1988) pp. 42–60.
- Friedenstein A. J., Chailakhyan R. K., Gerasimov U. V., Cell Tissue Kinet. 20, 263 (1987);
- Bab I., Howlett C. R., Ashton B. A., Owen M. E., ibid. 187, 243 (1984).
- We thank D. Fink J. Andres R. Deans F. Barry S Bruder M. Thiede A. Moseley and J. Burns for discussion and review of the manuscript; M. Black and M. Earlington for cell isolation from marrow; and D. Sterchi D. Brown and J. Skwarek for histology. This work was supported by Osiris Therapeutics (www.osiristx.com) and in part by a research contract from the Defense Advanced Research Projects Agency.
Cited by
Items 1,201–1,300 of 1,649
Electrospinning Approaches Toward Scaffold Engineering—A Brief Overview
Boudriot, U., Dersch, R., Greiner, A., & Wendorff, J. H. (2006) · Artificial Organs · doi:10.1111/j.1525-1594.2006.00301.x · Cited by 255
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells
Gojo, S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00132-0 · Cited by 255
“It was previously reported that human mesenchymal stem cells were successfully isolated and could differentiate into osteocytes, chondrocytes, and adipocytes [14].”
BackgroundBiology and therapeutic potential of mesenchymal stem cell‐derived exosomes
Xunian, Z., & Kalluri, R. (2020) · Cancer Science · doi:10.1111/cas.14563 · Cited by 255
Liang, W.-C., Fu, W.-M., Wang, Y.-B., Sun, Y.-X., Xu, L.-L., Wong, C.-W., Chan, K.-M., Li, G., Waye, M. M.-Y., & Zhang, J.-F. (2016) · Scientific Reports · doi:10.1038/srep20121 · Cited by 254
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells
Diekman, B. O., Christoforou, N., Willard, V. P., Sun, H., Sanchez-Adams, J., Leong, K. W., & Guilak, F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210422109 · Cited by 254
“The percentage of mesenchymal stem cells (MSCs) in bone marrow is low (8), whereas the more abundant adipose-derived stem cells (ASCs) appear to have reduced chondrogenic potential under current differentiation protocols (9).”
BackgroundArbab, A. S., Bashaw, L. A., Miller, B. R., Jordan, E. K., Bulte, J. W. M., & Frank, J. A. (2003) · Transplantation · doi:10.1097/01.tp.0000089237.39220.83 · Cited by 253
SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β‐catenin
Simic, P., Zainabadi, K., Bell, E., Sykes, D. B., Saez, B., Lotinun, S., Baron, R., Scadden, D., Schipani, E., & Guarente, L. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201606 · Cited by 253
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp265 · Cited by 253
Romagnani, P., Annunziato, F., Liotta, F., Lazzeri, E., Mazzinghi, B., Frosali, F., Cosmi, L., Maggi, L., Lasagni, L., Scheffold, A., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000177670.72216.9b · Cited by 253
Taléns-Visconti, R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5834 · Cited by 253
Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Satija, N. K., Singh, V. K., Verma, Y. K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R. P., & Gurudutta, G. U. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00857.x · Cited by 252
“These multi-potent cells are easily isolated from bone marrow and are capable of expansion and differentiation into mesodermal lineage cells including osteoblasts, chondrocytes and adipocytes, under appropriate conditions, in culture [1, 2].”
BackgroundInfluentialvan Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.017 · Cited by 252
Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model
Inoue, S., Popp, F. C., Koehl, G. E., Piso, P., Schlitt, H. J., Geissler, E. K., & Dahlke, M. H. (2006) · Transplantation · doi:10.1097/01.tp.0000209919.90630.7b · Cited by 252
“Moreover, MSCs can give rise to a typical set of stromal elements such as bone, cartilage, and adipose tissue (1).”
BackgroundZaragosi, L., Ailhaud, G., & Dani, C. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0006 · Cited by 252
Deasy, B. M., Lu, A., Tebbets, J. C., Feduska, J. M., Schugar, R. C., Pollett, J. B., Sun, B., Urish, K. L., Gharaibeh, B. M., Cao, B., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612094 · Cited by 251
“Adipogenic differentiation was induced after cells reached confl uency by adding adipogenic medium to the cells (dexamethasone, insulin, indomethacin, and 3-isobutyl-1-methylxanthinine; Cambrex) as previously described (Pittenger et al., 1999).”
MethodKim, Y., Park, H., Lee, G., Bang, O. Y., Ahn, Y. H., Joe, E., Kim, H. O., & Lee, P. H. (2009) · Glia · doi:10.1002/glia.20731 · Cited by 251
“MSCs are themselves capable of multipotency, with differentiation under appropriate conditions into chondrocytes, skeletal myocytes, and neurons (Makino et al., 1999; Pittenger et al., 1999; Woodbury et al., 2000).”
BackgroundTsigkou, O., Jones, J. R., Polak, J. M., & Stevens, M. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.019 · Cited by 251
“CD105 and CD166 surface markers have been used to define a bone marrow stromal cell population which is capable of multilineage differentiation and more specifically adipogenesis, chondrogenesis and osteogenesis [22].”
Chang, C., Yen, M., Chen, Y., Chien, C., Huang, H., Bai, C., & Yen, B. L. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0071 · Cited by 251
Delorme, B., Nivet, E., Gaillard, J., Häupl, T., Ringe, J., Devèze, A., Magnan, J., Sohier, J., Khrestchatisky, M., Roman, F. S., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0267 · Cited by 250
“As a consequence, proliferation remains within the Hayfl ick’s limit of 50 cell doublings [67,68].”
Yamada, Y., Seong Boo, J., Ozawa, R., Nagasaka, T., Okazaki, Y., Hata, K.-I., & Ueda, M. (2003) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/s1010-5182(02)00143-9 · Cited by 249
“Tissue engineering of bone regeneration by autogenous cell transplantation is one of the most promising treatment concepts being developed, as it eliminates the problems of donor site morbidity for autologous grafts, the immunogenicity of allogenic grafts, and loosening of alloplastic implants (Vacanti et al., 1988, 1…”
BackgroundThe immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy
Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M.-H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.019 · Cited by 248
“A key property of MSC is their multi-lineage differentiation potential [5].”
BackgroundZhang, X., Hirai, M., Cantero, S., Ciubotariu, R., Dobrila, L., Hirsh, A., Igura, K., Satoh, H., Yokomi, I., Nishimura, T., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23042 · Cited by 248
“M stem cells (MSC) have been studied extensively because of their high potential for multi-lineage differentiation and proliferation, characteristics that make the cells useful for therapeutic purposes [Pittenger et al., 1999; Caplan, 2007; Prockop, 2009; Salem and Thiemermann, 2010].”
BackgroundProgramming human pluripotent stem cells into white and brown adipocytes
Ahfeldt, T., Schinzel, R. T., Lee, Y.-K., Hendrickson, D., Kaplan, A., Lum, D. H., Camahort, R., Xia, F., Shay, J., Rhee, E. P., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2411 · Cited by 248
Cartilage tissue engineering: From biomaterials and stem cells to osteoarthritis treatments
Vinatier, C., & Guicheux, J. (2016) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2016.03.002 · Cited by 248
“MSCs can give rise to several types of differentiated cells, including chondrocytes, adipocytes, osteoblasts, and myogenic and neuronal cells [27].”
BackgroundChen, Q., Shou, P., Zhang, L., Xu, C., Zheng, C., Han, Y., Li, W., Huang, Y., Zhang, X., Shao, C., et al. (2014) · Stem Cells · doi:10.1002/stem.1567 · Cited by 248
“MSCs have great potential in stem cell-based therapies, due to their potent immunomodulatory properties [8] and their intrinsic ability to differentiate into multiple cell lineages, such as adipocytes, osteoblasts, chondrocytes, and neurons [9, 10].”
BackgroundMüller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M. P., et al. (2006) · Cytotherapy · doi:10.1080/14653240600920782 · Cited by 247
Greulich, C., Kittler, S., Epple, M., Muhr, G., & Köller, M. (2009) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-009-0472-1 · Cited by 247
“Furthermore, hMSC are found in different tissues such as bone marrow, fat, or muscle [18], and this cell type is intimately involved in tissue regeneration and tissue repair.”
BackgroundShin, J. Y., Park, H. J., Kim, H. N., Oh, S. H., Bae, J.-S., Ha, H.-J., & Lee, P. H. (2014) · Autophagy · doi:10.4161/auto.26508 · Cited by 243
Kurtzberg, J., Prockop, S., Teira, P., Bittencourt, H., Lewis, V., Chan, K. W., Horn, B., Yu, L., Talano, J.-A., Nemecek, E., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2013.11.001 · Cited by 246
Schwartz, S. D., Tan, G., Hosseini, H., & Nagiel, A. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18681 · Cited by 245
Fischer, J., Dickhut, A., Rickert, M., & Richter, W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27565 · Cited by 245
“MSCs can be easily obtained from different sources, such as bone marrow (6,7) and adipose tissue (8), and possess good proliferation and differentiation potential, including differentiation into a chondrogenic phenotype (8,9).”
BackgroundMelzer, C., Rehn, V., Yang, Y., Bähre, H., von der Ohe, J., & Hass, R. (2019) · Cancers · doi:10.3390/cancers11060798 · Cited by 245
“Evaluation of these primary four MSC cultures revealed adherence and constitutive expression of the core markers CD73, CD90, and CD105 in more than 90% of the individual cell populations, respectively, with simultaneous low to undetectable levels of CD45 consistent with MSC characterization guidelines [15,18,20] (Figu…”
ResultMesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization
Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J., Umezawa, A., Kijima, H., Fukuda, S., & Saijo, Y. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00157 · Cited by 244
Is CD34 truly a negative marker for mesenchymal stromal cells?
Lin, C.-S., Ning, H., Lin, G., & Lue, T. F. (2012) · Cytotherapy · doi:10.3109/14653249.2012.729817 · Cited by 239
Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable
Denu, R. A., Nemcek, S., Bloom, D. D., Goodrich, A. D., Kim, J., Mosher, D. F., & Hematti, P. (2016) · Acta Haematologica · doi:10.1159/000445096 · Cited by 242
“demonstrated that fibroblasts are incapable of differentiating into adipocytes, chondrocytes, and osteoblasts [8], while other studies show that fibroblasts do possess these differentiation capabilities [15,16].”
Backgroundde Windt, T. S., Vonk, L. A., Slaper-Cortenbach, I. C. M., van den Broek, M. P. H., Nizak, R., van Rijen, M. H. P., de Weger, R. A., Dhert, W. J. A., & Saris, D. B. F. (2017) · Stem Cells · doi:10.1002/stem.2475 · Cited by 242
Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells
de Boer, J., Siddappa, R., Gaspar, C., van Apeldoorn, A., Fodde, R., & van Blitterswijk, C. (2004) · Bone · doi:10.1016/j.bone.2004.01.016 · Cited by 241
“Human mesenchymal stem cells (hMSCs) are pluripotent cells from the bone marrow, which can be expanded in vitro and differentiated into the osteogenic, chondrogenic, and adipogenic lineages [36].”
BackgroundMesenchymal stem cell as salvage treatment for refractory chronic GVHD
Weng, J. Y., Du, X., Geng, S. X., Peng, Y. W., Wang, Z., Lu, Z. S., Wu, S. J., Luo, C. W., Guo, R., Ling, W., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.195 · Cited by 240
Amé-Thomas, P., Maby-El Hajjami, H., Monvoisin, C., Jean, R., Monnier, D., Caulet-Maugendre, S., Guillaudeux, T., Lamy, T., Fest, T., & Tarte, K. (2007) · Blood · doi:10.1182/blood-2006-05-020800 · Cited by 240
Targets, models and challenges in osteoarthritis research
Thysen, S., Luyten, F. P., & Lories, R. J. U. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.016881 · Cited by 239
“In humans, loss-of-function mutations in GDF5 cause severe skeletal phenotypes characterized by joint fusions (Polinkovsky et al., 1997; Thomas et al., 1997; Thomas et al., 1996).”
Clinical utility of stem cells for periodontal regeneration
Hynes, K., Menicanin, D., Gronthos, S., & Bartold, P. M. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00443.x · Cited by 239
“These systems are derived from at least three different stem-cell populations present in the bone marrow: hematopoietic stem cells, which give rise to blood cells; endothelial precursor cells, known as angioblasts; and different stromal populations derived from bone marrow stromal ⁄ stem cells (51, 57, 134).”
Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and Factors
Soleymaninejadian, E., Pramanik, K., & Samadian, E. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01069.x · Cited by 239
“Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Δ(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2 (2002) Antioxid Redox Signal, 4, pp.”
BackgroundRedondo-Castro, E., Cunningham, C., Miller, J., Martuscelli, L., Aoulad-Ali, S., Rothwell, N. J., Kielty, C. M., Allan, S. M., & Pinteaux, E. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0531-4 · Cited by 239
“type of multipotent stem cells that can be isolated and cultured from several tissues [1, 2] and differentiated into several cell lineages [3, 4].”
BackgroundTsonis, P. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9667 · Cited by 237
“…and DeFrances, 1997 Engeland et al., 1996 Experimentally induced (EGF, HGF) Kim et al., 1999 Booth et al., 1999; Sattar et al., 1999 Prockop, 1997; Pittenger et al., 1999 Cotsarelis et al., 1999 Inhibition of hepatocyte division, differentiation to oval cells Petersen et al., 1999 ammals Cameron…”
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I., Wei, Y., Starczynowski, D. T., Colla, S., Yang, H., Cabrero-Calvo, M., Bohannan, Z. S., Verma, A., Steidl, U., & Garcia-Manero, G. (2015) · Leukemia · doi:10.1038/leu.2015.69 · Cited by 236
Adipose-derived stromal cells: their identity and uses in clinical trials, an update
Casteilla, L. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i4.25 · Cited by 235
Organization of immunological memory by bone marrow stroma
Tokoyoda, K., Hauser, A. E., Nakayama, T., & Radbruch, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2727 · Cited by 236
“Mesenchymal stromal cells are so named because of their mesenchymal origi”
BackgroundThe myofibroblast, multiple origins for major roles in normal and pathological tissue repair
Micallef, L., Vedrenne, N., Billet, F., Coulomb, B., Darby, I. A., & Desmoulière, A. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s5 · Cited by 236
“These mesenchymal stem cells are bone marrow-derived non-hematopoietic precursor cells [31] that contribute to the maintenance and regeneration of connective tissues through engraftment.”
BackgroundThe Role of Stem Cells in Skeletal and Cardiac Muscle Repair
Grounds, M. D., White, J. D., Rosenthal, N., & Bogoyevitch, M. A. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000501 · Cited by 235
“…and other stem cells (including a small side population, termed SP cells, that exclude Hoechst stain) (Thomson et al. 1998; Gussoni et al. 1999; Pittenger et al. 1999; Young et al. 1999,2001b; Beauchamp et al. 2000; Jackson et al. 2001; Reyes and Verfaillie 2001), and Stem Cells in Skeletal…”
BackgroundThe effects of graphene nanostructures on mesenchymal stem cells
Talukdar, Y., Rashkow, J. T., Lalwani, G., Kanakia, S., & Sitharaman, B. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.054 · Cited by 235
“For differentiation studies, two representative differentiation pathways of MSCs, osteogenesis and adipogenesis, were chosen [50,51].”
Efficacy of Periodontal Stem Cell Transplantation in the Treatment of Advanced Periodontitis
Park, J.-Y., Jeon, S. H., & Choung, P.-H. (2011) · Cell Transplantation · doi:10.3727/096368910x519292 · Cited by 235
Koç, O. N., Peters, C., Aubourg, P., Raghavan, S., Dyhouse, S., DeGasperi, R., Kolodny, E. H., BenYoseph, Y., Gerson, S. L., Lazarus, H. M., et al. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00101-0 · Cited by 235
“We and others have shown that bone marrow contains mesenchymal stem cells (MSCs), which can differentiate into various tissues of mesenchymal origin [7], including stromal cells of the marrow [8], adipocytes, osteocytes, chondrocytes [9–11] and perhaps astrocytes [12,13].”
BackgroundOntogeny and nutritional control of adipogenesis in zebrafish (Danio rerio)
Flynn, E. J., Trent, C. M., & Rawls, J. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800590-jlr200 · Cited by 234
Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells
Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., & Bloch, W. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.010 · Cited by 233
“The differentiative potential of MSCs was evaluated by growing the cells under conditions favorable for adipogenic, osteogenic and chondrogenic differentiation [17,19].”
BackgroundKang, S. K., Shin, I. S., Ko, M. S., Jo, J. Y., & Ra, J. C. (2012) · Stem Cells International · doi:10.1155/2012/342968 · Cited by 232
“Multiple studies have demonstrated that cultured MSCs have the ability to differentiate into bone and cartilage [6, 7] as well as other cell types and tissues both in vitro and in vivo [2, 6, 8].”
BackgroundBos, C., Delmas, Y., Desmoulière, A., Solanilla, A., Hauger, O., Grosset, C., Dubus, I., Ivanovic, Z., Rosenbaum, J., Charbord, P., et al. (2004) · Radiology · doi:10.1148/radiol.2333031714 · Cited by 232
The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro
Wang, M., Yang, Y., Yang, D., Luo, F., Liang, W., Guo, S., & Xu, J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02891.x · Cited by 232
Improved Viability of Random Pattern Skin Flaps through the Use of Adipose-Derived Stem Cells
Lu, F., Mizuno, H., Uysal, C. A., Cai, X., Ogawa, R., & Hyakusoku, H. (2008) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000293876.10700.b8 · Cited by 231
Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells
Kanda, Y., Hinata, T., Kang, S. W., & Watanabe, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.06.007 · Cited by 231
De Becker, A., Van Hummelen, P., Bakkus, M., Vande Broek, I., De Wever, J., De Waele, M., & Van Riet, I. (2007) · Haematologica · doi:10.3324/haematol.10475 · Cited by 230
“It has been shown that a single MSC can give rise to different mesodermal cell types such as adipocytes, chondrocytes and osteocytes, if the appropriate stimuli are present in the growth medium.(2) In recent years it has become clear that MSC might have an even broader differentiation capacity.”
BackgroundInsights into Mesenchymal Stem Cell Aging: Involvement of Antioxidant Defense and Actin Cytoskeleton
Kasper, G., Mao, L., Geissler, S., Draycheva, A., Trippens, J., Kühnisch, J., Tschirschmann, M., Kaspar, K., Perka, C., Duda, G. N., et al. (2009) · Stem Cells · doi:10.1002/stem.49 · Cited by 230
Tang, N., Song, W., Luo, J., Luo, X., Chen, J., Sharff, K. A., Bi, Y., He, B., Huang, J., Zhu, G., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00569.x · Cited by 230
“Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd MSCs are adherent bone marrow stromal cells that can selfrenew and differentiate into osteogenic, chondrogenic, adipogenic and myogenic lineages [7, 18–22].”
BackgroundMitsiadis, T. A., Barrandon, O., Rochat, A., Barrandon, Y., & De Bari, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.027 · Cited by 230
“Other stem cells present in the bone marrow are the MSCs, which have the ability to self-renew and to differentiate into cartilage, bone and adipose tissue at the single cell level [32].”
BackgroundMapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths
Wolock, S. L., Krishnan, I., Tenen, D. E., Matkins, V., Camacho, V., Patel, S., Agarwal, P., Bhatia, R., Tenen, D. G., Klein, A. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.031 · Cited by 229
“The non-hematopoietic cells of the bone marrow microenvironment include multipotent stromal and/or stem cells (MSCs), which have been defined in culture by their capacity to differentiate into osteocytes, adipocytes, and chondrocytes (Ashton et al., 1980; Bab et al., 1986; Castro-Malaspina et al., 1980; Dominici et al…”
Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells
Liao, H.-T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i3.288 · Cited by 229
Shakibaei, M., Buhrmann, C., & Mobasheri, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198713 · Cited by 226
Replicative Aging and Gene Expression in Long-Term Cultures of Human Bone Marrow Stromal Cells
Banfi, A., Bianchi, G., Notaro, R., Luzzatto, L., Cancedda, R., & Quarto, R. (2002) · Tissue Engineering · doi:10.1089/107632702320934001 · Cited by 226
“40 It has been reported by Pittenger et al. 10 that putative human mesenchymal stem cells, isolated from bone marrow aspirates, display telomerase activity in vitro .”
Does Mesenchymal Stem Cell Therapy Help Multiple Sclerosis Patients? Report of a Pilot Study.
Bonab, M. M., Yazdanbakhsh, S., Lotfi, J., Alimoghaddom, K., Talebian, F., Hooshmand, F., Ghavamzadeh, A., & Nikbin, B. (2007) · PubMed · doi:10.22034/iji.2007.17180 · Cited by 226
Mesenchymal markers on human adipose stem/progenitor cells
Zimmerlin, L., Donnenberg, V. S., Rubin, J. P., & Donnenberg, A. D. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22227 · Cited by 225
CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties
Yang, Z. X., Han, Z.-B., Ji, Y. R., Wang, Y. W., Liang, L., Chi, Y., Yang, S. G., Li, L. N., Luo, W. F., Li, J. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059354 · Cited by 225
“MSCs were first isolated from bone marrow [4], and subsequently found in nearly every tissue attempted so far, including adipose [5], and several birth associated perinatal tissues including placenta [6], umbilical cord [7] and cord blood [8].”
BackgroundBone morphogenetic protein signaling in bone homeostasis
Sánchez-Duffhues, G., Hiepen, C., Knaus, P., & ten Dijke, P. (2015) · Bone · doi:10.1016/j.bone.2015.05.025 · Cited by 225
“ally, it has been considered that they derive from mesenchymal stem cells that differentiate into pre-OBs [16].”
BackgroundStem cells in bone tissue engineering
Seong, J. M., Kim, B.-C., Park, J.-H., Kwon, I. K., Mantalaris, A., & Hwang, Y.-S. (2010) · Biomedical Materials · doi:10.1088/1748-6041/5/6/062001 · Cited by 225
“BM-MSCs have been found to be positive for a variety of makers, such as STRO-1, CD105, SH3, CD29, CD44, CD71, CD90, CD106, CD120a, CD124, and other surface proteins (Pittenger et al 1999, Colter et al 2001).”
BackgroundBioreactor Systems for Bone Tissue Engineering
Rauh, J., Milan, F., Günther, K.-P., & Stiehler, M. (2011) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2010.0612 · Cited by 225
“MSCs have the potential to differentiate toward diverse mesenchymal lineages, including osteoblasts, chondrocytes, adipocytes, and myocytes.(17) Drawbacks of the application of MSCs are their limited availability and their in vitro replicative senescence.”
Lyons, F. G., Al-Munajjed, A. A., Kieran, S. M., Toner, M. E., Murphy, C. M., Duffy, G. P., & O’Brien, F. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.056 · Cited by 222
Markway, B. D., Tan, G.-K., Brooke, G., Hudson, J. E., Cooper-White, J. J., & Doran, M. R. (2010) · Cell Transplantation · doi:10.3727/096368909x478560 · Cited by 224
Chondrogenic Potential of Multipotential Cells from Human Adipose Tissue
Huang, J. I., Zuk, P. A., Jones, N. F., Zhu, M., Lorenz, H. P., Hedrick, M. H., & Benhaim, P. (2004) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000101063.27008.e1 · Cited by 224
Maul, T. M., Chew, D. W., Nieponice, A., & Vorp, D. A. (2011) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-010-0285-8 · Cited by 224
“The multipotentiality of the MSCs obtained from the TCGT was confirmed with 2week culture in expansion media supplemented with osteogenic or adipogenic biochemical agents (Pittenger et al. 1999; Hamilton et al. 2004) and assayed with the histochemical stains Alizarin Red (Sigma, St.”
MethodSmith, J. R., Pochampally, R., Perry, A., Hsu, S., & Prockop, D. J. (2004) · STEM CELLS · doi:10.1634/stemcells.22-5-823 · Cited by 224
Review: Ex Vivo Engineering of Living Tissues with Adult Stem Cells
Barrilleaux, B., Phinney, D. G., Prockop, D. J., & O'connor, K. C. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.3007 · Cited by 224
“(Thy-1), and CD105 (endoglin), and negative selection for hematopoietic markers CD34 and CD45.(36,44,45) BMSCs have also been isolated based on their light-scattering properties.”
Arai, F., Ohneda, O., Miyamoto, T., Zhang, X. Q., & Suda, T. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011700 · Cited by 223
Regenerative Potential of Embryonic Renal Multipotent Progenitors in Acute Renal Failure
Lazzeri, E., Crescioli, C., Ronconi, E., Mazzinghi, B., Sagrinati, C., Netti, G. S., Angelotti, M. L., Parente, E., Ballerini, L., Cosmi, L., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020210 · Cited by 223
Advances in Tissue Engineering
Levenberg, S., & Langer, R. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)61005-2 · Cited by 223
Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer
Sasser, A. K., Sullivan, N. J., Studebaker, A. W., Hendey, L. F., Axel, A. E., & Hall, B. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8832com · Cited by 222
“Mesenchymal stem cells (MSC), also referred to as bone marrow stromal cells, are a common fibroblastic cell population within bone that regulates hematopoiesis, has a robust ability to self-renew, can differentiate into multiple mesenchymal cell lineages, and constitutively produces IL-6 ( 14 , 15).”
BackgroundConcise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases
Volkman, R., & Offen, D. (2017) · Stem Cells · doi:10.1002/stem.2651 · Cited by 222
Deshmukh, V., Hu, H., Barroga, C., Bossard, C., KC, S., Dellamary, L., Stewart, J., Chiu, K., Ibanez, M., Pedraza, M., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.08.015 · Cited by 222
Adipose-Derived Stem Cells: Characterization and Current Application in Orthopaedic Tissue Repair
Tapp, H., Hanley, E. N., Patt, J. C., & Gruber, H. E. (2009) · Experimental Biology and Medicine · doi:10.3181/0805-mr-170 · Cited by 222
“Although some functional similarities between adult human fibroblasts and mesenchymal stem cells exist, such as characteristic surface markers and some differentiation ability (13), extensive characterization shows many functional differences (15, 16).”
BackgroundMesenchymal stem cells: properties and role in clinical bone marrow transplantation
Le Blanc, K., & Ringdén, O. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.07.004 · Cited by 221
Plasticity of marrow-derived stem cells
Krause, D. S. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301760 · Cited by 221
Connective Tissue Progenitors: Practical Concepts for Clinical Applications
Muschler, G. F., & Midura, R. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200202000-00008 · Cited by 221
Wang, Y., Cui, C.-B., Yamauchi, M., Miguez, P., Roach, M., Malavarca, R., Costello, J. M., Cardinale, V., Wauthier, E., Barbier, C., et al. (2011) · Hepatology · doi:10.1002/hep.24012 · Cited by 220
“Moreover, lineage restriction of MSCs to liver fates gives inconsistent results with adult cells having mixed hepatocyte and MSC phenotypes.(3,44,45) The hepatocyte-like cells from any of these precursors express some, but never all, of the major liver-specific genes, with variability in which genes are observed, and…”
BackgroundAnjos-Afonso, F., & Bonnet, D. (2007) · Blood · doi:10.1182/blood-2006-06-030551 · Cited by 220
Erickson, I. E., Huang, A. H., Chung, C., Li, R. T., Burdick, J. A., & Mauck, R. L. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0099 · Cited by 220
“20–22 In pellet cultures in defined media supplemented with TGF b = BMP superfamily members, 23 MSCs undergo chondrogenesis and deposit a proteoglycan-rich ECM.”
Gu, J., Qian, H., Shen, L., Zhang, X., Zhu, W., Huang, L., Yan, Y., Mao, F., Zhao, C., Shi, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052465 · Cited by 220
“MSCs could be induced to differentiate into osteocytes, adipocytes, chondrocytes and myocytes because of their regenerative ability and multipotent capacity [14].”
BackgroundAndreas, K., Georgieva, R., Ladwig, M., Mueller, S., Notter, M., Sittinger, M., & Ringe, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.064 · Cited by 220
“To determine detrimental effects of magnetic labeling on the tri-lineage differentiation capacity, SPION-labeled MSCs were cultivated under conditions that induce adipogenic, osteogenic and chondrogenic differentiation according to protocols described in previous studies [30,31].”
MethodMesenchymal stromal cells: tissue repair and immune modulation
Le Blanc, K. (2006) · Cytotherapy · doi:10.1080/14653240601045399 · Cited by 220
Zhou, X., Feng, W., Qiu, K., Chen, L., Wang, W., Nie, W., Mo, X., & He, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02636 · Cited by 219
Tipnis, S., Viswanathan, C., & Majumdar, A. S. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2010.47 · Cited by 218
Sakaguchi, Y., Sekiya, I., Yagishita, K., Ichinose, S., Shinomiya, K., & Muneta, T. (2004) · Blood · doi:10.1182/blood-2003-12-4452 · Cited by 218
Liu, H., Kemeny, D. M., Heng, B. C., Ouyang, H. W., Melendez, A. J., & Cao, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2864 · Cited by 217
Lee, P., Kim, J., Bang, O., Ahn, Y., Joo, I., & Huh, K. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100386 · Cited by 217
Metadata
- Authors
- Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R.
- Affiliations
- Osiris Therapeutics (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Pittenger, Mark F.
- ORCID
- Pittenger, Mark F.
- Venue
- Science
- Published
- 1999-04-02
- Volume
- 284
- Issue
- 5411
- Pages
- 143-147
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159999899
- Cited by
- 21,052
- References
- 37
- Citations by year
- 2026: 265 · 2025: 373 · 2024: 497 · 2023: 541 · 2022: 604 · 2021: 778 · 2020: 856 · 2019: 766 · 2018: 884 · 2017: 962 · 2016: 1083 · 2015: 1145 · 2014: 1255 · 2013: 1344 · 2012: 1384
- FWCI
- 138.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, multilineage differentiation, multipotency, bone marrow, adipogenesis, chondrogenic differentiation, osteogenic differentiation, stem cell isolation, colony expansion, stem cell phenotype
- MeSH terms
- Adult, Bone Marrow Cells, Cell Differentiation, Cell Division, Cell Separation, Cells, Cultured, Fibroblasts, Flow Cytometry, Humans, Mesoderm, Middle Aged, Osteocytes, Phenotype, Stem Cells, Apoptosis, Adipocytes, Cell Lineage, Chondrocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.